We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+23.21%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1B
AUM Growth
+$154M
Cap. Flow
+$86.2M
Cap. Flow %
8.59%
Top 10 Hldgs %
45.9%
Holding
94
New
30
Increased
21
Reduced
13
Closed
27

Top Buys

Rank Stock Value
1
POST icon
Post Holdings
POST
+$25.4M
2
CMG icon
Chipotle Mexican Grill
CMG
+$23.3M
3
HBI
Hanesbrands
HBI
+$20.8M
4
UAA icon
Under Armour
UAA
+$20.2M
5
HOG icon
Harley-Davidson
HOG
+$18.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$22.4M
2
NOMD icon
Nomad Foods
NOMD
+$21.7M
3
INCY icon
Incyte
INCY
+$17M
4
ADMS
Adamas Pharmaceuticals
ADMS
+$15.9M
5
DKS icon
Dick's Sporting Goods
DKS
+$13.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.41%
2 Consumer Discretionary 28.7%
3 Consumer Staples 9.04%
4 Industrials 2.93%
5 Financials 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRMR icon
51
Larimar Therapeutics
LRMR
$398M
$4.32M 0.43%
78,000
+46,333
+146% +$2.09M
APRN
52
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$4.03M 0.4%
+5,556
New +$4.16M
FRTX
53
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$3.66M 0.36%
+6,349
New +$4.18M
ATNM icon
54
Actinium Pharmaceuticals
ATNM
$26.8M
$2.96M 0.3%
148,800
+2,733
+2% +$55K
ATEC icon
55
Alphatec Holdings
ATEC
$1.33B
$2.07M 0.21%
778,414
+120,000
+18% +$384K
AVEO
56
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.67M 0.17%
+60,000
New +$1.86M
SEEL
57
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$1.56M 0.16%
7
-6
-46% -$1.2M
IPCI
58
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$1.55M 0.15%
+193,600
New +$1.76M
DYNT
59
DELISTED
Dynatronics Corp
DYNT
$1.5M 0.15%
104,378
+2,354
+2% +$29.6K
KPRX icon
60
Kiora Pharmaceuticals
KPRX
$11.3M
$1.37M 0.14%
238
-61
-20% -$377K
ANTH
61
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$1.27M 0.13%
+768,915
New +$1.32M
AYTU icon
62
AYTU BioPharma
AYTU
$22.1M
$818K 0.08%
+92
New +$1.1M
MBAI
63
Check-Cap
MBAI
$8.27M
$651K 0.06%
+3,117
New +$959K
AIXC
64
AIxCrypto Holdings Inc
AIXC
$16.7M
$626K 0.06%
15
– –
FCSC
65
DELISTED
Fibrocell Science Inc.
FCSC
$393K 0.04%
+122,779
New +$1.07M
TMBR
66
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$382K 0.04%
+231
New +$630K
ANF icon
67
Abercrombie & Fitch
ANF
$4.41B
– –
-700,000
Closed -$10.1M
CPB icon
68
CALL
Campbell Soup
CPB
$6.67B
– –
-500,000
Closed -$23.4M
DECK icon
69
CALL
Deckers Outdoor
DECK
$13.6B
– –
-3,000,000
Closed -$34.2M
DKS icon
70
Dick's Sporting Goods
DKS
$18.4B
– –
-500,000
Closed -$13.8M
ETSY icon
71
Etsy
ETSY
$7.96B
– –
-400,000
Closed -$6.75M
INCY icon
72
Incyte
INCY
$23.7B
– –
-146,000
Closed -$17M
NOMD icon
73
Nomad Foods
NOMD
$1.67B
– –
-1,488,000
Closed -$21.7M
PII icon
74
Polaris
PII
$4.25B
– –
-100,000
Closed -$10.5M
REGN icon
75
Regeneron Pharmaceuticals
REGN
$69.9B
– –
-50,000
Closed -$22.4M
1 2
3
4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Armistice Capital held 94 positions worth $1B, up 18% from $849M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Armistice Capital deployed $86.2M of net new capital in Q4 2017, opening 30 new positions and adding to 21 existing holdings. Its largest new stake was Post Holdings: 476,736 shares worth $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Madrigal Pharmaceuticals, an estimated $8.68M trimmed.

  • Armistice Capital's largest Q4 2017 buy was Post Holdings: 476,736 shares worth $24.7M.
  • Armistice Capital added most to Hanesbrands in Q4 2017, an estimated $20.8M increase.
  • Armistice Capital's biggest Q4 2017 reduction was Madrigal Pharmaceuticals, cutting an estimated $8.68M.
  • Armistice Capital fully exited Regeneron Pharmaceuticals in Q4 2017, selling an estimated $22.4M.
  • Armistice Capital's ten largest holdings make up 46% of its $1B portfolio in Q4 2017.
  • Armistice Capital opened 30 new positions and closed 27 in Q4 2017.
  • Armistice Capital's portfolio value rose 18% quarter-over-quarter to $1B.

Based on Armistice Capital's 13F filing for Q4 2017, filed 14 Feb 2018.